Psychosis during chronic levodopa therapy triggered by the new antidepressive drug mirtazapine

Pharmacopsychiatry
C NormannJ Walden

Abstract

We report the case of a patient developing psychosis after the addition of mirtazapine, a novel antidepressant enhancing serotonergic neurotransmission, to a chronic levodopa regimen. There was complete and rapid recovery upon low-dose clozapine treatment. To our knowledge, this is the first published case of a mirtazapine-levodopa interaction and the second case report of a psychosis induced by a serotonergic antidepressant in a patient with Parkinson's disease (PD). This phenomenon might be due to a postsynaptic serotonin receptor supersensitization caused by low central serotonin levels in treated PD.

Citations

Sep 16, 2010·Current Treatment Options in Neurology·Laura B Zahodne, Hubert H Fernandez
May 27, 2010·International Psychogeriatrics·Kalpana P PadalaWilliam J Burke
Dec 1, 2012·International Psychogeriatrics·Tomoyuki NagataKazuhiko Nakayama
Jul 31, 2008·Drugs & Aging·Laura B Zahodne, Hubert H Fernandez
Jul 15, 2004·Clinical Neuropharmacology·Valerie Voon, Anthony E Lang
Jul 12, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·David J Burn
Dec 5, 2002·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·D J Burn
Oct 11, 2014·Expert Review of Clinical Pharmacology·Martin BroadstockAnne Corbett
Sep 1, 2011·Progress in Neurobiology·Philippe HuotJonathan M Brotchie
Jan 30, 2010·Parkinsonism & Related Disorders·Heinz ReichmannMatthias Löhle
Aug 6, 2013·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Kenji TagaiKazuhiko Nakayama
Jan 15, 2015·Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Österreichischer Nervenärzte und Psychiater·Jacopo Vittoriano BizzarriHans Peter Kapfhammer
Mar 27, 2015·Parkinson's Disease·Philippe HuotJonathan M Brotchie
Jul 9, 2016·Progress in Neurobiology·Philippe De DeurwaerdèreMark J Millan
Jul 20, 2005·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·F J E Vajda, C Solinas
Oct 20, 2017·Expert Opinion on Drug Discovery·Zeyad T Sahli, Frank I Tarazi
Sep 12, 2018·Clinical Neuropharmacology·Grace H Lee, Jonathan T Stewart
Sep 22, 2006·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Carmine NieuwstratenAnne Holbrook

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Progress in Neuro-psychopharmacology & Biological Psychiatry
G Meco, Silvia Bernardi
European Psychiatry : the Journal of the Association of European Psychiatrists
I-Shin ShiahSy-Ueng Luu
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
L MorganteA Quattrone
© 2021 Meta ULC. All rights reserved